Comparison of the Efficacy of Sitagliptin with Pioglitazone on the Control of Diabetic Patients
Phase 3
- Conditions
- Diabetes mellitus type 2.Diabetes mellitus?E10-E14
- Registration Number
- IRCT201704246712N3
- Lead Sponsor
- Vice Chancellor for Research of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Diabetics Type II; taking complete doze of Metformin (1500-2000mg) and a Sulfonylurea (15-20mg); age range from 30 to 65; 7% = HbAlc; Reluctance to take insulin; willingness to participate in the study. Exclusion criteria: pregnant patient; patients with heart failure; patients with renal insufficiency; patients with bladder cancer background; Glycemic severe complications including DKA; Reluctance to participate in the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: Before treatment and three months after starting the drug. Method of measurement: Test.;HbA1C. Timepoint: Before treatment and three months after starting the drug. Method of measurement: Test.
- Secondary Outcome Measures
Name Time Method